Recap: TherapeuticsMD Q3 Earnings

 

TherapeuticsMD TXMD reported its Q3 earnings results on Thursday, November 11, 2021 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

TherapeuticsMD their estimated earnings by 10.0%, reporting an EPS of $-0.11 versus an estimate of $-0.1, which did not surprise analysts.

Revenue was up $6,064,000 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0, which was followed by a 3.07% increase in the share price the next day.

Here's a look at TherapeuticsMD's past performance:

 

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020
EPS Estimate -0.11 -0.12 -0.10 -0.14
EPS Actual -0.11 -0.11 -0.15 -0.12
Revenue Estimate 22.11M 19.77M 21.89M 15.33M
Revenue Actual 23.00M 19.87M 22.58M 19.34M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!